| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F6-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F6-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F6-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate |
2005-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008505718-A |
| titleOfInvention |
Sustained release composition containing a progesterone receptor modulator |
| abstract |
Sustained release compositions for vaginal or transdermal administration containing progesterone receptor modulators such as CDB-2914 (also referred to as VA-2914) and methods of using them for long periods of time for contraceptive or therapeutic purposes are disclosed The A method for making the composition is also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328022-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013522361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014210802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018016655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011518845-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015503544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017517288-A |
| priorityDate |
2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |